Metcalf, Donald
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Donald Metcalf Australian medical researcher (1929–2014)
Metcalf, Donald, 1929-2014
Metcalf, D.
Metcalf, D. (Donald)
VIAF ID: 22201569 (Personal)
Permalink: http://viaf.org/viaf/22201569
Preferred Forms
-
100 0 _
‡a
Donald Metcalf
‡c
Australian medical researcher (1929–2014)
-
200 _ |
‡a
Metcalf
‡b
Donald
-
100 1 _
‡a
Metcalf, D.
-
100 1 _ ‡a Metcalf, D. ‡q (Donald)
-
100 1 _ ‡a Metcalf, Donald
-
100 1 _
‡a
Metcalf, Donald
-
100 1 _ ‡a Metcalf, Donald
-
100 1 _
‡a
Metcalf, Donald
-
100 1 _
‡a
Metcalf, Donald
-
100 1 _ ‡a Metcalf, Donald
-
100 1 _ ‡a Metcalf, Donald
-
100 1 _ ‡a Metcalf, Donald ‡d (1929-2014).
-
100 1 _
‡a
Metcalf, Donald
‡d
1929-2014
-
100 1 _ ‡a Metcalf, Donald, ‡d 1929-2014
4xx's: Alternate Name Forms (14)
5xx's: Related Names (8)
- 551 _ _
‡a
Mittagong
‡4
ortg
‡4
https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 510 2 _
‡a
Pezcoller Symposium on Normal and Malignant Hematopoiesis: New Advances (1994 : Revereto, Trento, Italy)
- 510 2 _
‡a
University of Melbourne
- 510 2 _
‡a
University of Melbourne
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
- 510 2 _
‡a
University of Sydney
- 510 2 _
‡a
Walter and Eliza Hall Institute of Medical Research
- 510 2 _
‡a
Walter and Eliza Hall Institute of Medical Research
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
- 510 2 _
‡a
Wistar Institute of Anatomy and Biology
Works
| Title | Sources |
|---|---|
| Clonal culture of hemopoietic cells : techniques and applications |
|
| A convenient method for preparation of an engineered mouse interleukin-3 analog with high solubility and wild-type bioactivity. |
|
| Correction for Zhang et al., The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation |
|
| The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12 |
|
| Crowding-dependent production of colony-stimulating factors by cultured syngeneic or allogeneic hematopoietic cells |
|
| Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice |
|
| Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. |
|
| Distinct roles for leukemia inhibitory factor receptor alpha-chain and gp130 in cell type-specific signal transduction |
|
| Enforced expression of the homeobox gene Mixl1 impairs hematopoietic differentiation and results in acute myeloid leukemia |
|
| Functional analysis of Asb-1 using genetic modification in mice |
|
| Genetic reduction of embryonic leukemia-inhibitory factor production rescues placentation in SOCS3-null embryos but does not prevent inflammatory disease |
|
| Granulocyte colony-stimulating factor and neutrophils--forgotten mediators of inflammatory disease |
|
| Hematopoiesis : a developmental approach |
|
| Hematopoietic defects in the Ts1Cje mouse model of Down syndrome |
|
| Hemopoietic colonies : in vitro cloning of normal and leukemic cells |
|
| hemopoietic colony-stimulating factors from biology to clinical applications |
|
| International Conference on Leukemia and Aplastic Anemia : proceedings of the International Conference held in Naples, September 16-18, 1974 |
|
| Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes |
|
| A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency |
|
| Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. |
|
| The lethal effects of transplantation of Socs1-/- bone marrow cells into irradiated adult syngeneic recipients |
|
| Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. |
|
| Lymphoid tissue and plasmacytoid dendritic cells and macrophages do not share a common macrophage-dendritic cell-restricted progenitor |
|
| Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression |
|
| molecular control of blood cells |
|
| Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation |
|
| Multipotential hematopoietic blast colony-forming cells exhibit delays in self-generation and lineage commitment. |
|
| Murine hematopoietic blast colony-forming cells and their progeny have distinctive membrane marker profiles |
|
| Murine megakaryocyte progenitor cells and their susceptibility to suppression by G-CSF |
|
| A mutation in the translation initiation codon of Gata-1 disrupts megakaryocyte maturation and causes thrombocytopenia |
|
| MYC levels govern hematopoietic tumor type and latency in transgenic mice |
|
| The nature of myeloid leukaemia |
|
| Neutrophils Require SHP1 To Regulate IL-1 Production and Prevent Inflammatory Skin Disease |
|
| NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells |
|
| Normal and malignant hematopoiesis : new advances |
|
| A novel mutation in the Nfkb2 gene generates an NF-kappa B2 "super repressor". |
|
| Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor alpha chain expression on activated B cells. |
|
| Platelet production proceeds independently of the intrinsic and extrinsic apoptosis pathways |
|
| Polycomb repressive complex 2 |
|
| Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1). |
|
| The preleukemic state of mice reconstituted with Mixl1-transduced marrow cells |
|
| Programmed anuclear cell death delimits platelet life span. |
|
| A promising new treatment for refractory aplastic anemia |
|
| The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism |
|
| PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis |
|
| Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells |
|
| Reduced Lymphocyte Longevity and Homeostatic Proliferation in Lamin B Receptor-Deficient Mice Results in Profound and Progressive Lymphopenia |
|
| Reversible growth factor dependency and autonomy during murine myelomonocytic leukemia induced by oncogenes |
|
| RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis |
|
| SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation |
|
| The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo |
|
| SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. |
|
| SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. |
|
| Socs3 maintains the specificity of biological responses to cytokine signals during granulocyte and macrophage differentiation |
|
| SOCS3 negatively regulates IL-6 signaling in vivo |
|
| SOCS5 is expressed in primary B and T lymphoid cells but is dispensable for lymphocyte production and function |
|
| Stem cell factor can stimulate the formation of eosinophils by two types of murine eosinophil progenitor cells |
|
| Suckling defect in mice lacking the soluble haemopoietin receptor NR6. |
|
| Summon up the blood : in dogged pursuit of the blood cell regulators |
|
| Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation |
|
| Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity |
|
| Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130 |
|
| Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection |
|
| Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling |
|
| Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling |
|
| Synergistic and inhibitory interactions in the in vitro control of murine megakaryocyte colony formation |
|
| Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene |
|
| Thrombopoietin and hematopoietic stem cells |
|
| The thymus; a symposium held at the Wistar Institute of Anatomy and Biology, April 29, 1964. |
|
| The thymus : its role in immune responses, leukaemia development, and carcinogenesis |
|
| A training manual for cancer research workers |
|
| Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance |
|
| Transgenic expression of GM-CSF in T cells causes disseminated histiocytosis. |
|
| Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia |
|
| Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome |
|
| The unsolved enigmas of leukemia inhibitory factor |
|
| Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice |
|
